AptameX Production and Commercialization Update
28 avr. 2022 08h15 HE
|
Achiko AG
Company has commenced shipping and will book first sales in May 2022Reorganized production line able to meet stronger than expected demand for Achiko AG’s innovative DNA aptamer saliva-based rapid...
Achiko AG Signs Major Marketing and Sales Agreement with World’s Largest Islamic Association for its AptameX Covid-19 Rapid Test
20 avr. 2022 07h45 HE
|
Achiko AG
Signed major deal with Pengurus Wilayah Nahdlatul Ulama DKI Jakarta, for the use of Covid-19 test AptameX in general assemblies and activities. Located primarily in Indonesia, Nahdlatul Ulama is the...
Pfizer und BioNTech veröffentlichen Daten zu starker Immunantwort nach Auffrischungsimpfung mit dem COVID-19-Impfstoff bei Kindern im Alter von 5 bis 11 Jahren
14 avr. 2022 06h45 HE
|
BioNTech SE
Daten einer Subanalyse mit 30 Seren aus einer klinischen Phase-2/3-Studie mit Kindern im Alter von 5 bis 11 Jahren zeigen einen 36-fachen Anstieg der neutralisierenden Antikörpertiter gegen die...
Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age
14 avr. 2022 06h45 HE
|
BioNTech SE
Data from a subanalysis of 30 sera from a Phase 2/3 clinical trial of children 5 through 11 years of age show a 36-fold increase in SARS-CoV-2 Omicron neutralizing titers following a booster (third)...
Epygen Biotech Announces Funding from India Government for Development of a COVID-19 Vaccine Using Dyadic’s Licensed C1 Protein Production Platform
13 avr. 2022 08h52 HE
|
Dyadic International, Inc.
India’s Department of Biotechnology, Government of India to support scale up and production of cGMP batches of SARS-CoV-2 antigenFunding earmarked to support Phase 1 and 2 clinical trials of Epygen’s...
Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
15 mars 2022 18h00 HE
|
BioNTech SE
Submission based on real-world safety and efficacy data from Israel Data showed rates of confirmed infections were 2 times lower and rates of severe illness were 4 times lower among individuals who...
Achiko AG Production and Sales Update
03 mars 2022 07h30 HE
|
Achiko AG
Unique Chemistry with DNA Aptamers Completing Pre-Sales Validation TestingCompleting Pre-Sales Validation Testing in Indonesia ZURICH, Switzerland, March 03, 2022 (GLOBE NEWSWIRE) -- Ad...
Achiko AG Research Paper and Commercialization Update
14 févr. 2022 07h30 HE
|
Achiko AG
Calibration study results now available in draft paper on medRxiv, a preprint platform for health sciences, as “DNA Aptamer Gold Nanoparticle Colorimetric Diagnostic Test Kit of Saliva Samples for...
LSU CEE Professor Bivins Studying Wastewater on International Flights
07 févr. 2022 11h00 HE
|
LSU College of Engineering
BATON ROUGE, La., Feb. 07, 2022 (GLOBE NEWSWIRE) -- With the COVID-19 Omicron variant spreading like wildfire, testing has never been more important. This is why LSU Civil & Environmental...
Ogena Solutions and Puraclenz launch Next Generation Air and Surface Purifier Technology in the fight against Omicron
03 févr. 2022 11h38 HE
|
Ogena Solutions
STONEY CREEK, Ontario, Feb. 03, 2022 (GLOBE NEWSWIRE) -- With no end in sight for the Covid-19 pandemic and with the highly contagious Omicron variant causing devastating outcomes, it’s quite clear...